Dr. Katalin Kauser joined Alucent Biomedical after 20 years in the pharmaceutical industry. She has specialized throughout her career in cardiovascular research aimed at developing innovative therapeutics for treating ischemic cardiac disease, atherosclerosis, systemic hypertension, chronic kidney disease, pulmonary hypertension, pulmonary fibrosis, heart failure, and hematologic disorders. Prior to joining Alucent Biomedical, she most recently served as the Senior Vice President of Biology and a member of the executive management team at Global Blood Therapeutics. In addition, she has held senior leadership positions in a number of cardiovascular-focused therapy companies.
Dr. Kauser is a recognized vascular biologist in the fields of endothelial dysfunction and endothelial nitric oxide synthase regulation. She holds a Doctor of Medicine from Semmelweiss Medical University and a Ph.D. and D.Sc. in physiology and medical sciences from the Hungarian Academy of Science.